ASH Clinical News ACN_3.12s_OCT_SUPP

Now Approved in a New Indication Give More Patients the OPDIVO Opportunity. For latest information and indications, please visit www.OPDIVO.com/hcp OPDIVO® and the related logo are trademarks of Bristol-Myers Squibb Company. © 2017 Bristol-Myers Squibb Company. All rights reserved. 1506US1701894-01-01 06/17